Dr Calvin Stiller and Dr Ronald Cresswell have appointed to the board of directors of Vasogen Inc, a Toronto-based developer of technologies targetting inflammation related to cardiovascular and neurological diseases. Stiller has a strong medical and venture capital background, while Cresswell is a veteran executive of several multinational pharmaceuti